Multiple skin tumors in a patient treated with orelabrutinib for mantle-cell lymphoma: Case report
Orelabrutinib may be associated with multiple skin tumors, and the mechanism may be through complex immune dysregulation. It is recommended that patients receiving long-term BTKi therapy undergo regular dermatological examinations.
Authors
- Lei Zeng (ORCID: https://orcid.org/0000-0002-4459-6841)
- Yuxi Zhang (ORCID: https://orcid.org/0000-0003-3558-2939)
- Xuefeng Fu (ORCID: https://orcid.org/0000-0002-7205-1080)
- Qiying Zhang (ORCID: https://orcid.org/0009-0008-4397-9788)
- Xuefeng Fu (ORCID: https://orcid.org/0009-0002-7994-8568)
Institutions
- Jinhua Academy of Agricultural Sciences (CN)
- Guang Fu Hospital (CN)
- Jinhua Central Hospital (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1097/md.0000000000046417
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00